|
시장보고서
상품코드
2076060
CRISPR 유전자 치료 시장 : 제품 유형별, 용도별, 최종 사용자별, 지역별CRISPR Genomic Cure Market, By Product Type, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
CRISPR 유전자 치료 시장은 2026년에 55억 8,000만 달러 규모에 이를 것으로 추정되고 있어 2033년까지 208억 1,000만 달러에 이를 것으로 예상되고 있습니다. 2026년부터 2033년까지 CAGR 20.7%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 55억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간 CAGR : | 20.70% | 2033년 시장 규모 예측 : | 208억 1,000만 달러 |
세계 CRISPR 유전자 치료 시장은 키트 및 시약, 라이브러리, 벡터 설계 등의 제품 유형으로 구성되어 있으며, 종양학, 유전성 질환, 유전자 공학 등의 분야에 활용되고 있습니다. 이러한 제품들은 바이오의약품 기업, 위탁 연구 기관(CRO), 유전자 연구실 등 다양한 분야에서 채택되어 효율성, 성능 및 신뢰성 향상에 기여하고 있습니다. 이러한 부문에서의 채용 확대와 지속적인 제품 혁신이 맞물려 시장 확대를 지속적으로 뒷받침하고 있습니다.
시장 역학:
주요 응용 분야 수요 증가, 효율성과 성능에 대한 중요성 부각, 그리고 지속적인 제품 혁신이 전 세계 CRISPR 유전자 치료 시장의 성장을 견인할 것으로 예상되는 주요 요인입니다. 바이오의약품 기업 및 위탁 연구 기관(CRO)의 채용 확대와 첨단 솔루션에 대한 투자 증가가 시장 성장을 더욱 뒷받침하고 있습니다.
예를 들어, 각 제약사는 종양학 및 관련 용도에 맞춘 솔루션 개발을 점점 더 적극적으로 추진하고 있습니다. 또한, 지속적인 연구 개발과 신기술의 통합을 통해 예측 기간 동안 시장 참여자들에게 새로운 성장 기회가 창출될 것으로 전망됩니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 CRISPR 유전자 치료 시장의 주요 기업 프로파일을 소개했습니다.
- 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 세계 CRISPR 유전자 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 CRISPR 유전자 치료 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 CRISPR 유전자 치료 시장
제5장 세계의 CRISPR 유전자 치료 시장 : 제품 유형별, 2021-2033년
제6장 세계의 CRISPR 유전자 치료 시장 : 용도별, 2021-2033년
제7장 세계의 CRISPR 유전자 치료 시장 : 최종 사용자별, 2021-2033년
제8장 세계의 CRISPR 유전자 치료 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
JHS 26.07.09CRISPR Genomic Cure Market is estimated to be valued at USD 5.58 Bn in 2026 and is expected to reach USD 20.81 Bn by 2033, growing at a compound annual growth rate (CAGR) of 20.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.58 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 20.70% | 2033 Value Projection: | USD 20.81 Bn |
The global crispr genomic cure market comprises product type categories such as Kits & Reagents, Libraries, and Vector Design, serving applications including Oncology, Genetic Diseases, and Genomic Engineering. These offerings are adopted across Biopharmaceutical Companies, Contract Research Organizations (CROs), and Genetic Research Laboratories and other areas, where they support improved efficiency, performance, and reliability. Growing adoption across these segments, combined with ongoing product innovation, continues to support expansion of the market.
Market Dynamics:
Rising demand across key application areas, increasing emphasis on efficiency and performance, and continued product innovation are major factors expected to drive growth of the global crispr genomic cure market. Expanding adoption among Biopharmaceutical Companies, and Contract Research Organizations (CROs) and growing investment in advanced solutions are further supporting market expansion.
For instance, providers are increasingly developing offerings tailored to Oncology and related applications. Moreover, ongoing research and development, along with the integration of new technologies, is expected to create new growth opportunities for market players over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global crispr genomic cure market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., Origene Technologies, Inc., New England Biolabs, Intellia Therapeutics, Inc., GenScript, GeneCopoeia, Inc., Cellectis, Mammoth Biosciences, Precision Biosciences, Inc., Synthego Corporation, CRISPR Therapeutics, Horizon Discovery Group plc, Lonza Group Ltd., and Takara Bio Inc, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global crispr genomic cure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global crispr genomic cure market.
Detailed Segmentation:
- Global CRISPR Genomic Cure Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
- Kits & Reagents
- Libraries
- Vector Design
- Assay Design
- Others
- Global CRISPR Genomic Cure Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Genetic Diseases
- Genomic Engineering
- Others
- Global CRISPR Genomic Cure Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Genetic Research Laboratories
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Merck KGaA*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Thermo Fisher Scientific Inc.
- Origene Technologies, Inc.
- New England Biolabs
- Intellia Therapeutics, Inc.
- GenScript
- GeneCopoeia, Inc.
- Cellectis
- Mammoth Biosciences
- Precision Biosciences, Inc.
- Synthego Corporation
- CRISPR Therapeutics
- Horizon Discovery Group plc
- Lonza Group Ltd.
- Takara Bio Inc
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- CRISPR Genomic Cure Market, By Product Type
- CRISPR Genomic Cure Market, By Application
- CRISPR Genomic Cure Market, By End User
- CRISPR Genomic Cure Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Global CRISPR Genomic Cure Market
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global CRISPR Genomic Cure Market, By Product Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Kits & Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Libraries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Vector Design
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Assay Design
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global CRISPR Genomic Cure Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Genetic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Genomic Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global CRISPR Genomic Cure Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Genetic Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Global CRISPR Genomic Cure Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- UK
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- India
- China
- Japan
- Australia
- South Korea
- ASEAN
- Rest of the APAC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Origene Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- New England Biolabs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intellia Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GeneCopoeia, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cellectis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mammoth Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Precision Biosciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Synthego Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CRISPR Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Horizon Discovery Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
